#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
AAC_2___Ic.3002525.AL123456.3.314308_314854.4719	AAC_2___Ic.3002525.AL123456.3.314308_314854.4719	1	0	27	324	AAC_2___Ic	546	546	100.0	AAC_2___Ic.l15.c30.ctg.1	993	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	b"AAC(2')-Ic is a chromosomal-encoded aminoglycoside acetyltransferase in M. tuberculosis and Mycobacterium tuberculosis variant bovis.";AAC(2')-Ic
Erm_37_.3000392.AL123456.1.2231679_2232219.582	Erm_37_.3000392.AL123456.1.2231679_2232219.582	1	0	27	264	Erm_37_	540	540	100.0	Erm_37_.l15.c4.ctg.1	1176	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	b'Erm(37) is found in Mycobacterium species and confers the MLSb phenotype. In addition to methylation of A2058 this Erm methylates adjacent adenosines (A2057 and A2059) as well.';Erm(37)
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	A1744G	SNP	1744	1744	A	7	7	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	T1751C	SNP	1751	1751	T	14	14	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	T1798C	SNP	1798	1798	T	61	61	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	A1820G	SNP	1820	1820	A	83	83	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	A1841C	SNP	1841	1841	A	104	104	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	G1914A	SNP	1914	1914	G	177	177	A	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	C1923T	SNP	1923	1923	C	186	186	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	C1957T	SNP	1957	1957	C	220	220	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	T1974G	SNP	1974	1974	T	237	237	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	.2074C	INS	2074	2074	C	338	338	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	.2079G	INS	2079	2079	A	344	344	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	C2194T	SNP	2194	2194	C	459	459	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	G2301A	SNP	2301	2301	G	566	566	A	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	C2346T	SNP	2346	2346	C	611	611	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	A2347C	SNP	2347	2347	A	612	612	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	T2358G	SNP	2358	2358	T	623	623	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	A2361G	SNP	2361	2361	A	626	626	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	T2362C	SNP	2362	2362	T	627	627	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	A2399G	SNP	2399	2399	A	664	664	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	C2402T	SNP	2402	2402	C	667	667	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	G2408C	SNP	2408	2408	G	673	673	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	T2418A	SNP	2418	2418	T	684	684	A	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	C2427T	SNP	2427	2427	C	693	693	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	C2429G	SNP	2429	2429	C	695	695	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	T2498G	SNP	2498	2498	T	764	764	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	A2526G	SNP	2526	2526	A	792	792	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	G2536A	SNP	2536	2536	G	802	802	A	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	C2593T	SNP	2593	2593	C	859	859	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	A2895G	SNP	2895	2895	A	1161	1161	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	T2896C	SNP	2896	2896	T	1162	1162	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	T2906C	SNP	2906	2906	T	1172	1172	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	A2909G	SNP	2909	2909	A	1175	1175	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	A2915G	SNP	2915	2915	A	1181	1181	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	G2920C	SNP	2920	2920	G	1186	1186	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	A2940T	SNP	2940	2940	A	1206	1206	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	T3002C	SNP	3002	3002	T	1268	1268	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	A3005G	SNP	3005	3005	A	1271	1271	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	A3007T	SNP	3007	3007	A	1273	1273	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	C3028A	SNP	3028	3028	C	1294	1294	A	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	G3038A	SNP	3038	3038	G	1304	1304	A	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	T3045C	SNP	3045	3045	T	1311	1311	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	C3062T	SNP	3062	3062	C	1328	1328	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	A3067G	SNP	3067	3067	A	1333	1333	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	C3071T	SNP	3071	3071	C	1337	1337	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	A3083G	SNP	3083	3083	A	1349	1349	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	1366	96.06	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.1	1476	0.0	1	SNP	n	A2268C	0	.	.	2268	2268	A	533	533	A	ND	ND	ND	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159:0:0:A2268C:.:b'Point mutation in the 23S rRNA of Mycobaccterium avium shown to confer resistance to azithromycin, a macrolide type antibiotic.'	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	272	97.79	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	491	0.0	0	.	n	.	0	T8C	SNP	8	8	T	227	227	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	272	97.79	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	491	0.0	0	.	n	.	0	A96G	SNP	96	96	A	315	315	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	272	97.79	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	491	0.0	0	.	n	.	0	T98G	SNP	98	98	T	317	317	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	272	97.79	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	491	0.0	0	.	n	.	0	T146C	SNP	146	146	T	365	365	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	272	97.79	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	491	0.0	0	.	n	.	0	A217G	SNP	217	217	A	436	436	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	512	88	Mycobacterium_intracellulare_23S_1	3103	272	97.79	Mycobacterium_intracellulare_23S_1.l15.c4.ctg.2	491	0.0	0	.	n	.	0	T238C	SNP	238	238	T	457	457	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	1375	97.67	Mycobacterium_kansasii_23S.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	A1741G	SNP	1741	1741	A	7	7	G	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	1375	97.67	Mycobacterium_kansasii_23S.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	A1838C	SNP	1838	1838	A	104	104	C	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	1375	97.67	Mycobacterium_kansasii_23S.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	C1920T	SNP	1920	1920	C	186	186	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	1375	97.67	Mycobacterium_kansasii_23S.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	T1950C	SNP	1950	1950	T	216	216	C	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	1375	97.67	Mycobacterium_kansasii_23S.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	A1971G	SNP	1971	1971	A	237	237	G	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	1375	97.67	Mycobacterium_kansasii_23S.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	G2300A	SNP	2300	2300	G	566	566	A	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	1375	97.67	Mycobacterium_kansasii_23S.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	A2347G	SNP	2347	2347	A	613	613	G	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	1375	97.67	Mycobacterium_kansasii_23S.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	T2361C	SNP	2361	2361	T	627	627	C	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	1375	97.67	Mycobacterium_kansasii_23S.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	A2398G	SNP	2398	2398	A	664	664	G	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	1375	97.67	Mycobacterium_kansasii_23S.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	C2401T	SNP	2401	2401	C	667	667	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	1375	97.67	Mycobacterium_kansasii_23S.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	G2407C	SNP	2407	2407	G	673	673	C	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	1375	97.67	Mycobacterium_kansasii_23S.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	C2427T	SNP	2427	2427	C	693	693	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	1375	97.67	Mycobacterium_kansasii_23S.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	C2429G	SNP	2429	2429	C	695	695	G	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	1375	97.67	Mycobacterium_kansasii_23S.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	T2498G	SNP	2498	2498	T	764	764	G	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	1375	97.67	Mycobacterium_kansasii_23S.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	G2536A	SNP	2536	2536	G	802	802	A	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	1375	97.67	Mycobacterium_kansasii_23S.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	C2563T	SNP	2563	2563	C	829	829	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	1375	97.67	Mycobacterium_kansasii_23S.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	C2593T	SNP	2593	2593	C	859	859	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	1375	97.67	Mycobacterium_kansasii_23S.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	T2609C	SNP	2609	2609	T	875	875	C	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	1375	97.67	Mycobacterium_kansasii_23S.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	T2611C	SNP	2611	2611	T	877	877	C	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	1375	97.67	Mycobacterium_kansasii_23S.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	G2841A	SNP	2841	2841	G	1107	1107	A	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	1375	97.67	Mycobacterium_kansasii_23S.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	A2892G	SNP	2892	2892	A	1158	1158	G	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	1375	97.67	Mycobacterium_kansasii_23S.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	A2909G	SNP	2909	2909	A	1175	1175	G	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	1375	97.67	Mycobacterium_kansasii_23S.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	T2931C	SNP	2931	2931	T	1197	1197	C	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	1375	97.67	Mycobacterium_kansasii_23S.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	A2940T	SNP	2940	2940	A	1206	1206	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	1375	97.67	Mycobacterium_kansasii_23S.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	C2991T	SNP	2991	2991	C	1257	1257	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	1375	97.67	Mycobacterium_kansasii_23S.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	G3038A	SNP	3038	3038	G	1304	1304	A	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	1375	97.67	Mycobacterium_kansasii_23S.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	C3044T	SNP	3044	3044	C	1310	1310	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	1375	97.67	Mycobacterium_kansasii_23S.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	A3067G	SNP	3067	3067	A	1333	1333	G	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	1375	97.67	Mycobacterium_kansasii_23S.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	A3071T	SNP	3071	3071	A	1337	1337	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	1375	97.67	Mycobacterium_kansasii_23S.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	A3083G	SNP	3083	3083	A	1349	1349	G	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	1375	97.67	Mycobacterium_kansasii_23S.l15.c4.ctg.1	1476	0.0	0	.	n	.	0	C3103.	DEL	3103	3103	C	1368	1368	A	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	1375	97.67	Mycobacterium_kansasii_23S.l15.c4.ctg.1	1476	0.0	1	SNP	n	A2265U	0	.	.	2265	2265	A	531	531	A	ND	ND	ND	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178:0:0:A2265U:.:b'Point mutation in the 23S rRNA of Mycobacterium kansasii shown to confer resistance to clarithromycin, a macrolide type antibiotic.'	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	276	97.46	Mycobacterium_kansasii_23S.l15.c4.ctg.2	491	0.0	0	.	n	.	0	A74T	SNP	74	74	A	290	290	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	276	97.46	Mycobacterium_kansasii_23S.l15.c4.ctg.2	491	0.0	0	.	n	.	0	T149C	SNP	149	149	T	365	365	C	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	276	97.46	Mycobacterium_kansasii_23S.l15.c4.ctg.2	491	0.0	0	.	n	.	0	A220G	SNP	220	220	A	436	436	G	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	276	97.46	Mycobacterium_kansasii_23S.l15.c4.ctg.2	491	0.0	0	.	n	.	0	A231T	SNP	231	231	A	447	447	T	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	276	97.46	Mycobacterium_kansasii_23S.l15.c4.ctg.2	491	0.0	0	.	n	.	0	T241C	SNP	241	241	T	457	457	C	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	Mycobacterium_kansasii_23S.3004168.NZ_CP019883.1.5018387_5021505.4178	0	0	512	104	Mycobacterium_kansasii_23S	3118	276	97.46	Mycobacterium_kansasii_23S.l15.c4.ctg.2	491	0.0	0	.	n	.	0	T268.	DEL	268	268	T	483	483	A	ND	ND	ND	.	Mycobacterium kansasii 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921	Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921	0	0	513	220	Mycobacterium_tuberculosis_16S_4	1537	698	100.0	Mycobacterium_tuberculosis_16S_4.l15.c30.ctg.1	871	0.0	1	SNP	n	A1401G	0	.	.	1401	1401	A	562	562	A	ND	ND	ND	Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921:0:0:A1401G:.:b"Point mutations in the 3' domain of 16S rRNA of Mycobacterium tuberculosis can confer resistance to capreomycin."	Mycobacterium tuberculosis 16S rRNA mutation conferring resistance to capreomycin
Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921	Mycobacterium_tuberculosis_16S.3004853.AL123456.3.1471845_1473382.5921	0	0	513	220	Mycobacterium_tuberculosis_16S_4	1537	858	99.88	Mycobacterium_tuberculosis_16S_4.l15.c30.ctg.2	1139	0.0	0	.	n	.	0	C832G	SNP	832	832	C	1113	1113	G	ND	ND	ND	.	Mycobacterium tuberculosis 16S rRNA mutation conferring resistance to capreomycin
Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	1	1	27	672	Mycobacterium_tuberculosis_Rv1258c_1	1260	1260	100.0	Mycobacterium_tuberculosis_Rv1258c_1.l15.c17.ctg.1	1527	0.0	1	SNP	p	V219A	0	.	.	655	657	GTC	855	857	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483:1:1:V219A:.:b'Mutations in the M. tuberculosis efflux pump Rv1258c (Tap) conferring resistance to pyrazinamide, isoniazid, and streptomycin.'	Mycobacterium tuberculosis Rv1258c mutations confer resistance to pyrazinamide, isoniazid, and streptomycin
Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	1	1	27	672	Mycobacterium_tuberculosis_Rv1258c_1	1260	1260	100.0	Mycobacterium_tuberculosis_Rv1258c_1.l15.c17.ctg.1	1527	0.0	1	SNP	p	S292L	0	.	.	874	876	TCG	1074	1076	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483:1:1:S292L:.:b'Mutations in the M. tuberculosis efflux pump Rv1258c (Tap) conferring resistance to pyrazinamide, isoniazid, and streptomycin.'	Mycobacterium tuberculosis Rv1258c mutations confer resistance to pyrazinamide, isoniazid, and streptomycin
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	590	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c4.ctg.1	2235	0.0	1	SNP	p	R13C	0	.	.	37	39	CGT	450	452	CGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:R13C:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	590	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c4.ctg.1	2235	0.0	1	SNP	p	V18A	0	.	.	52	54	GTG	465	467	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:V18A:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	590	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c4.ctg.1	2235	0.0	1	SNP	p	L50V	0	.	.	148	150	CTG	561	563	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:L50V:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	590	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c4.ctg.1	2235	0.0	1	SNP	p	T110A	0	.	.	328	330	ACC	741	743	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:T110A:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	590	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c4.ctg.1	2235	0.0	1	SNP	p	R268H	0	.	.	802	804	CGC	1215	1217	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:R268H:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	590	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c4.ctg.1	2235	0.0	1	SNP	p	A300P	0	.	.	898	900	GCC	1311	1313	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:A300P:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	590	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c4.ctg.1	2235	0.0	1	SNP	p	G313R	0	.	.	937	939	GGG	1350	1352	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:G313R:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	590	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c4.ctg.1	2235	0.0	1	SNP	p	G339A	0	.	.	1015	1017	GGG	1428	1430	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:G339A:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	691	95.66	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1005	0.0	0	.	n	.	0	T863C	SNP	863	863	T	50	50	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	691	95.66	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1005	0.0	0	.	n	.	0	A870G	SNP	870	870	A	57	57	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	691	95.66	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1005	0.0	0	.	n	.	0	T975C	SNP	975	975	T	162	162	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	691	95.66	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1005	0.0	0	.	n	.	0	C977T	SNP	977	977	C	164	164	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	691	95.66	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1005	0.0	0	.	n	.	0	A990G	SNP	990	990	A	177	177	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	691	95.66	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1005	0.0	0	.	n	.	0	T1086C	SNP	1086	1086	T	273	273	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	691	95.66	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1005	0.0	0	.	n	.	0	G1098A	SNP	1098	1098	G	285	285	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	691	95.66	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1005	0.0	0	.	n	.	0	G1099C	SNP	1099	1099	G	286	286	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	691	95.66	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1005	0.0	0	.	n	.	0	C1107T	SNP	1107	1107	C	294	294	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	691	95.66	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1005	0.0	0	.	n	.	0	G1119A	SNP	1119	1119	G	306	306	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	691	95.66	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1005	0.0	0	.	n	.	0	A1211G	SNP	1211	1211	A	398	398	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	691	95.66	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1005	0.0	0	.	n	.	0	G1217A	SNP	1217	1217	G	404	404	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	691	95.66	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1005	0.0	0	.	n	.	0	A1228T	SNP	1228	1228	A	415	415	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	691	95.66	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1005	0.0	0	.	n	.	0	T1233C	SNP	1233	1233	T	420	420	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	691	95.66	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1005	0.0	0	.	n	.	0	A1234G	SNP	1234	1234	A	421	421	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	691	95.66	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1005	0.0	0	.	n	.	0	G1239T	SNP	1239	1239	G	426	426	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	691	95.66	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1005	0.0	0	.	n	.	0	G1240A	SNP	1240	1240	G	427	427	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	691	95.66	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1005	0.0	0	.	n	.	0	C1250T	SNP	1250	1250	C	437	437	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	691	95.66	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1005	0.0	0	.	n	.	0	T1252A	SNP	1252	1252	T	439	439	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	691	95.66	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1005	0.0	0	.	n	.	0	T1258C	SNP	1258	1258	T	445	445	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	691	95.66	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1005	0.0	0	.	n	.	0	T1274C	SNP	1274	1274	T	461	461	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	691	95.66	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1005	0.0	0	.	n	.	0	A1295G	SNP	1295	1295	A	482	482	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	691	95.66	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1005	0.0	0	.	n	.	0	T1419C	SNP	1419	1419	T	606	606	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	691	95.66	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1005	0.0	0	.	n	.	0	T1420G	SNP	1420	1420	T	607	607	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	691	95.66	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1005	0.0	1	SNP	n	A1375G	0	.	.	1375	1375	A	562	562	A	ND	ND	ND	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256:0:0:A1375G:.:b'Point mutations in the 16S rRNA of Mycobacteroides abscessus conferring resistance to gentamicin.'	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	691	95.66	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1005	0.0	1	SNP	n	C1376U	0	.	.	1376	1376	C	563	563	C	ND	ND	ND	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256:0:0:C1376U:.:b'Point mutations in the 16S rRNA of Mycobacteroides abscessus conferring resistance to gentamicin.'	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	691	95.66	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	1005	0.0	1	SNP	n	G1458U	0	.	.	1458	1458	G	645	645	G	ND	ND	ND	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256:0:0:G1458U:.:b'Point mutations in the 16S rRNA of Mycobacteroides abscessus conferring resistance to gentamicin.'	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	832	93.63	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	1116	0.0	0	.	n	.	0	C69T	SNP	69	69	C	338	338	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	832	93.63	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	1116	0.0	0	.	n	.	0	.75A	INS	75	75	G	345	345	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	832	93.63	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	1116	0.0	0	.	n	.	0	G77A	SNP	77	77	G	347	347	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	832	93.63	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	1116	0.0	0	.	n	.	0	T129C	SNP	129	129	T	399	399	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	832	93.63	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	1116	0.0	0	.	n	.	0	C174G	SNP	174	174	C	444	444	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	832	93.63	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	1116	0.0	0	.	n	.	0	C176A	SNP	176	176	C	446	446	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	832	93.63	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	1116	0.0	0	.	n	.	0	T178G	SNP	178	178	T	448	448	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	832	93.63	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	1116	0.0	0	.	n	.	0	G183T	SNP	183	183	G	453	453	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	832	93.63	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	1116	0.0	0	.	n	.	0	A186T	SNP	186	186	A	456	456	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	832	93.63	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	1116	0.0	0	.	n	.	0	C193G	SNP	193	193	C	463	463	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	832	93.63	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	1116	0.0	0	.	n	.	0	.196GC	INS	196	196	A	467	467	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	832	93.63	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	1116	0.0	0	.	n	.	0	T202A	SNP	202	202	T	474	474	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	832	93.63	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	1116	0.0	0	.	n	.	0	T249C	SNP	249	249	T	521	521	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	832	93.63	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	1116	0.0	0	.	n	.	0	C254T	SNP	254	254	C	526	526	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	832	93.63	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	1116	0.0	0	.	n	.	0	A291T	SNP	291	291	A	563	563	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	832	93.63	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	1116	0.0	0	.	n	.	0	A392G	SNP	392	392	A	664	664	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	832	93.63	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	1116	0.0	0	.	n	.	0	T428C	SNP	428	428	T	700	700	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	832	93.63	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	1116	0.0	0	.	n	.	0	G431C	SNP	431	431	G	703	703	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	832	93.63	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	1116	0.0	0	.	n	.	0	.438GTC	INS	438	438	G	711	711	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	832	93.63	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	1116	0.0	0	.	n	.	0	A441G	SNP	441	441	A	725	725	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	832	93.63	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	1116	0.0	0	.	n	.	0	G444T	SNP	444	444	G	728	728	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	832	93.63	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	1116	0.0	0	.	n	.	0	C453G	SNP	453	453	C	737	737	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	832	93.63	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	1116	0.0	0	.	n	.	0	A456G	SNP	456	456	A	740	740	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	832	93.63	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	1116	0.0	0	.	n	.	0	C457G	SNP	457	457	C	741	741	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	832	93.63	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	1116	0.0	0	.	n	.	0	G466C	SNP	466	466	G	750	750	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	832	93.63	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	1116	0.0	0	.	n	.	0	C509G	SNP	509	509	C	793	793	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	832	93.63	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	1116	0.0	0	.	n	.	0	A575T	SNP	575	575	A	859	859	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	832	93.63	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	1116	0.0	0	.	n	.	0	A581G	SNP	581	581	A	865	865	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	832	93.63	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	1116	0.0	0	.	n	.	0	G593A	SNP	593	593	G	877	877	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	832	93.63	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	1116	0.0	0	.	n	.	0	T741G	SNP	741	741	T	1025	1025	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	513	144	Mycobacteroides_abscessus_16S_4	1504	832	93.63	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	1116	0.0	0	.	n	.	0	C806G	SNP	806	806	C	1090	1090	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	128	Mycobacteroides_chelonae_16S_4	1441	978	96.42	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	1171	0.0	0	.	n	.	0	C489G	SNP	489	489	C	26	26	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	128	Mycobacteroides_chelonae_16S_4	1441	978	96.42	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	1171	0.0	0	.	n	.	0	A555T	SNP	555	555	A	92	92	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	128	Mycobacteroides_chelonae_16S_4	1441	978	96.42	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	1171	0.0	0	.	n	.	0	A561G	SNP	561	561	A	98	98	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	128	Mycobacteroides_chelonae_16S_4	1441	978	96.42	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	1171	0.0	0	.	n	.	0	G573A	SNP	573	573	G	110	110	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	128	Mycobacteroides_chelonae_16S_4	1441	978	96.42	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	1171	0.0	0	.	n	.	0	T721G	SNP	721	721	T	258	258	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	128	Mycobacteroides_chelonae_16S_4	1441	978	96.42	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	1171	0.0	0	.	n	.	0	T843C	SNP	843	843	T	380	380	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	128	Mycobacteroides_chelonae_16S_4	1441	978	96.42	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	1171	0.0	0	.	n	.	0	A850G	SNP	850	850	A	387	387	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	128	Mycobacteroides_chelonae_16S_4	1441	978	96.42	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	1171	0.0	0	.	n	.	0	G947A	SNP	947	947	G	484	484	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	128	Mycobacteroides_chelonae_16S_4	1441	978	96.42	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	1171	0.0	0	.	n	.	0	A956G	SNP	956	956	A	493	493	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	128	Mycobacteroides_chelonae_16S_4	1441	978	96.42	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	1171	0.0	0	.	n	.	0	T969C	SNP	969	969	T	506	506	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	128	Mycobacteroides_chelonae_16S_4	1441	978	96.42	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	1171	0.0	0	.	n	.	0	A970G	SNP	970	970	A	507	507	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	128	Mycobacteroides_chelonae_16S_4	1441	978	96.42	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	1171	0.0	0	.	n	.	0	C986T	SNP	986	986	C	523	523	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	128	Mycobacteroides_chelonae_16S_4	1441	978	96.42	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	1171	0.0	0	.	n	.	0	C1065T	SNP	1065	1065	C	602	602	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	128	Mycobacteroides_chelonae_16S_4	1441	978	96.42	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	1171	0.0	0	.	n	.	0	T1066C	SNP	1066	1066	T	603	603	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	128	Mycobacteroides_chelonae_16S_4	1441	978	96.42	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	1171	0.0	0	.	n	.	0	G1079C	SNP	1079	1079	G	616	616	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	128	Mycobacteroides_chelonae_16S_4	1441	978	96.42	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	1171	0.0	0	.	n	.	0	C1086G	SNP	1086	1086	C	623	623	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	128	Mycobacteroides_chelonae_16S_4	1441	978	96.42	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	1171	0.0	0	.	n	.	0	C1087T	SNP	1087	1087	C	624	624	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	128	Mycobacteroides_chelonae_16S_4	1441	978	96.42	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	1171	0.0	0	.	n	.	0	A1098G	SNP	1098	1098	A	635	635	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	128	Mycobacteroides_chelonae_16S_4	1441	978	96.42	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	1171	0.0	0	.	n	.	0	G1099A	SNP	1099	1099	G	636	636	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	128	Mycobacteroides_chelonae_16S_4	1441	978	96.42	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	1171	0.0	0	.	n	.	0	A1191G	SNP	1191	1191	A	728	728	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	128	Mycobacteroides_chelonae_16S_4	1441	978	96.42	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	1171	0.0	0	.	n	.	0	G1197A	SNP	1197	1197	G	734	734	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	128	Mycobacteroides_chelonae_16S_4	1441	978	96.42	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	1171	0.0	0	.	n	.	0	A1208T	SNP	1208	1208	A	745	745	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	128	Mycobacteroides_chelonae_16S_4	1441	978	96.42	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	1171	0.0	0	.	n	.	0	A1214G	SNP	1214	1214	A	751	751	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	128	Mycobacteroides_chelonae_16S_4	1441	978	96.42	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	1171	0.0	0	.	n	.	0	G1220A	SNP	1220	1220	G	757	757	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	128	Mycobacteroides_chelonae_16S_4	1441	978	96.42	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	1171	0.0	0	.	n	.	0	C1230T	SNP	1230	1230	C	767	767	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	128	Mycobacteroides_chelonae_16S_4	1441	978	96.42	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	1171	0.0	0	.	n	.	0	T1232A	SNP	1232	1232	T	769	769	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	128	Mycobacteroides_chelonae_16S_4	1441	978	96.42	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	1171	0.0	0	.	n	.	0	T1238C	SNP	1238	1238	T	775	775	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	128	Mycobacteroides_chelonae_16S_4	1441	978	96.42	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	1171	0.0	0	.	n	.	0	T1254C	SNP	1254	1254	T	791	791	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	128	Mycobacteroides_chelonae_16S_4	1441	978	96.42	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	1171	0.0	0	.	n	.	0	A1275G	SNP	1275	1275	A	812	812	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	128	Mycobacteroides_chelonae_16S_4	1441	978	96.42	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	1171	0.0	0	.	n	.	0	T1397C	SNP	1397	1397	T	934	934	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	128	Mycobacteroides_chelonae_16S_4	1441	978	96.42	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	1171	0.0	0	.	n	.	0	T1400G	SNP	1400	1400	T	937	937	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	528	128	Mycobacteroides_chelonae_16S_4	1441	978	96.42	Mycobacteroides_chelonae_16S_4.l15.c30.ctg.1	1171	0.0	1	SNP	n	A1355G	0	.	.	1355	1355	A	892	892	A	ND	ND	ND	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271:0:0:A1355G:.:b'Point mutations in the 16S rRNA of Mycobacteroides chelonae can cause resistance to neomycin.'	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
blaC.3007182.AL123456.3.2325885_2326809.8481	blaC.3007182.AL123456.3.2325885_2326809.8481	1	0	27	478	blaC	924	924	100.0	blaC.l15.c4.ctg.1	1811	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	b'blaC is a broad-spectrum class A beta-lactamase coded in the chromosome of Mycobacterium tuberculosis. It has been shown to hydrolyze a large number of beta-lactam antibiotics and is a major obstacle in the treatment of tuberculosis with such drugs.';blaC
efpA.3003955.AL123456.3.3153038_3154631.5259	efpA.3003955.AL123456.3.3153038_3154631.5259	1	0	27	704	efpA	1593	1593	100.0	efpA.l15.c4.ctg.1	2561	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	b'efpA is an MFS transporter found in Mycobacterium tuberculosis.';efpA
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	523	1226	embA	3285	3285	100.0	embA.l6.c4.ctg.1	3968	0.0	1	SNP	p	D4N	0	.	.	10	12	GAC	311	313	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:D4N:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	523	1226	embA	3285	3285	100.0	embA.l6.c4.ctg.1	3968	0.0	1	SNP	p	G5S	0	.	.	13	15	GGT	314	316	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:G5S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	523	1226	embA	3285	3285	100.0	embA.l6.c4.ctg.1	3968	0.0	1	SNP	p	A201T	0	.	.	601	603	GCG	902	904	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:A201T:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	523	1226	embA	3285	3285	100.0	embA.l6.c4.ctg.1	3968	0.0	1	SNP	p	G321S	0	.	.	961	963	GGC	1262	1264	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:G321S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	523	1226	embA	3285	3285	100.0	embA.l6.c4.ctg.1	3968	0.0	1	SNP	p	G350D	0	.	.	1048	1050	GGC	1349	1351	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:G350D:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	523	1226	embA	3285	3285	100.0	embA.l6.c4.ctg.1	3968	0.0	1	SNP	p	A462V	0	.	.	1384	1386	GCG	1685	1687	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:A462V:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	523	1226	embA	3285	3285	100.0	embA.l6.c4.ctg.1	3968	0.0	1	SNP	p	D833A	0	.	.	2497	2499	GAC	2798	2800	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:D833A:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	523	1226	embA	3285	3285	100.0	embA.l6.c4.ctg.1	3968	0.0	1	SNP	p	P913S	0	.	.	2737	2739	CCG	3038	3040	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:P913S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	523	1226	embA	3285	77	98.7	embA.l6.c4.ctg.2	460	0.0	0	.	p	.	0	W550R	NONSYN	1648	1650	TGG	53	55	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	L239P	0	.	.	715	717	CTG	822	824	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:L239P:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	D240H	0	.	.	718	720	GAC	825	827	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D240H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	S297A	0	.	.	889	891	TCG	996	998	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:S297A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	D299E	0	.	.	895	897	GAC	1002	1004	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D299E:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	M306I	0	.	.	916	918	ATG	1023	1025	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M306I:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	M306T	0	.	.	916	918	ATG	1023	1025	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M306T:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	M306V	0	.	.	916	918	ATG	1023	1025	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M306V:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	M306L	0	.	.	916	918	ATG	1023	1025	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M306L:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	D311H	0	.	.	931	933	GAC	1038	1040	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D311H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	Y319C	0	.	.	955	957	TAT	1062	1064	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Y319C:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	Y319N	0	.	.	955	957	TAT	1062	1064	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Y319N:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	D328Y	0	.	.	982	984	GAT	1089	1091	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D328Y:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	D328G	0	.	.	982	984	GAT	1089	1091	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D328G:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	F330V	0	.	.	988	990	TTC	1095	1097	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:F330V:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	Y333C	0	.	.	997	999	TAT	1104	1106	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Y333C:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	Y334H	0	.	.	1000	1002	TAC	1107	1109	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Y334H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	A356V	0	.	.	1066	1068	GCC	1173	1175	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:A356V:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	A357S	0	.	.	1069	1071	GCC	1176	1178	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:A357S:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	E368A	0	.	.	1102	1104	GAG	1209	1211	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:E368A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	P375A	0	.	.	1123	1125	CCG	1230	1232	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:P375A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	E378A	0	.	.	1132	1134	GAG	1239	1241	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:E378A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	S380R	0	.	.	1138	1140	AGC	1245	1247	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:S380R:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	P397Q	0	.	.	1189	1191	CCG	1296	1298	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:P397Q:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	N399H	0	.	.	1195	1197	AAC	1302	1304	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:N399H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	G406A	0	.	.	1216	1218	GGC	1323	1325	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G406A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	G406S	0	.	.	1216	1218	GGC	1323	1325	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G406S:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	G406D	0	.	.	1216	1218	GGC	1323	1325	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G406D:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	G406C	0	.	.	1216	1218	GGC	1323	1325	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G406C:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	L413P	0	.	.	1237	1239	CTG	1344	1346	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:L413P:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	P446H	0	.	.	1336	1338	CCC	1443	1445	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:P446H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	R460C	0	.	.	1378	1380	CGC	1485	1487	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:R460C:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	I465D	0	.	.	1393	1395	ATC	1500	1502	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:I465D:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	R469P	0	.	.	1405	1407	CGT	1512	1514	CGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:R469P:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	R471P	0	.	.	1411	1413	CGC	1518	1520	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:R471P:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	Q497K	0	.	.	1489	1491	CAG	1596	1598	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Q497K:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	Q497R	0	.	.	1489	1491	CAG	1596	1598	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Q497R:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	E504Q	0	.	.	1510	1512	GAA	1617	1619	GAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:E504Q:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	R507G	0	.	.	1519	1521	AGG	1626	1628	AGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:R507G:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	G745D	0	.	.	2233	2235	GGC	2340	2342	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G745D:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	D959A	0	.	.	2875	2877	GAC	2982	2984	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D959A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	M1000R	0	.	.	2998	3000	ATG	3105	3107	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M1000R:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	1438	embB_1	3297	3297	100.0	embB_1.l15.c4.ctg.1	3655	0.0	1	SNP	p	D1024N	0	.	.	3070	3072	GAC	3177	3179	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D1024N:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1402	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3883	0.0	1	SNP	p	R738Q	1	R738Q	NONSYN	2212	2214	CGG	2568	2570	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:R738Q:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1402	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3883	0.0	1	SNP	p	A247P	0	.	.	739	741	GCG	1095	1097	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:A247P:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1402	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3883	0.0	1	SNP	p	L251R	0	.	.	751	753	CTG	1107	1109	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:L251R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1402	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3883	0.0	1	SNP	p	A254G	0	.	.	760	762	GCC	1116	1118	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:A254G:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1402	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3883	0.0	1	SNP	p	T270I	0	.	.	808	810	ACC	1164	1166	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:T270I:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1402	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3883	0.0	1	SNP	p	H285Y	0	.	.	853	855	CAT	1209	1211	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:H285Y:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1402	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3883	0.0	1	SNP	p	V287F	0	.	.	859	861	GTC	1215	1217	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:V287F:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1402	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3883	0.0	1	SNP	p	G288W	0	.	.	862	864	GGG	1218	1220	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G288W:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1402	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3883	0.0	1	SNP	p	G288V	0	.	.	862	864	GGG	1218	1220	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G288V:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1402	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3883	0.0	1	SNP	p	Y296S	0	.	.	886	888	TAC	1242	1244	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y296S:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1402	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3883	0.0	1	SNP	p	Y296H	0	.	.	886	888	TAC	1242	1244	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y296H:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1402	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3883	0.0	1	SNP	p	I297L	0	.	.	889	891	ATC	1245	1247	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:I297L:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1402	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3883	0.0	1	SNP	p	I297T	0	.	.	889	891	ATC	1245	1247	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:I297T:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1402	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3883	0.0	1	SNP	p	M300R	0	.	.	898	900	ATG	1254	1256	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:M300R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1402	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3883	0.0	1	SNP	p	R302G	0	.	.	904	906	CGG	1260	1262	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:R302G:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1402	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3883	0.0	1	SNP	p	V303G	0	.	.	907	909	GTG	1263	1265	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:V303G:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1402	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3883	0.0	1	SNP	p	A307T	0	.	.	919	921	GCG	1275	1277	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:A307T:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1402	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3883	0.0	1	SNP	p	G308D	0	.	.	922	924	GGC	1278	1280	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G308D:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1402	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3883	0.0	1	SNP	p	Y309N	0	.	.	925	927	TAT	1281	1283	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y309N:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1402	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3883	0.0	1	SNP	p	M310K	0	.	.	928	930	ATG	1284	1286	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:M310K:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1402	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3883	0.0	1	SNP	p	G325S	0	.	.	973	975	GGC	1329	1331	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G325S:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1402	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3883	0.0	1	SNP	p	W326R	0	.	.	976	978	TGG	1332	1334	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:W326R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1402	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3883	0.0	1	SNP	p	Y327N	0	.	.	979	981	TAC	1335	1337	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y327N:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1402	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3883	0.0	1	SNP	p	N394D	0	.	.	1180	1182	AAC	1536	1538	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:N394D:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1402	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3883	0.0	1	SNP	p	P398S	0	.	.	1192	1194	CCC	1548	1550	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:P398S:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1402	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3883	0.0	1	SNP	p	Q491R	0	.	.	1471	1473	CAG	1827	1829	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Q491R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1402	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3883	0.0	1	SNP	p	L502P	0	.	.	1504	1506	CTC	1860	1862	CTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:L502P:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1402	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3883	0.0	1	SNP	p	V981L	0	.	.	2941	2943	GTG	3297	3299	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:V981L:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embR.3003455.AL123456.3.1416180_1417347.4712	embR.3003455.AL123456.3.1416180_1417347.4712	1	1	27	618	embR	1167	1167	100.0	embR.l6.c4.ctg.1	2149	0.0	1	SNP	p	C110Y	0	.	.	328	330	TGC	880	882	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embR.3003455.AL123456.3.1416180_1417347.4712:1:1:C110Y:.:b'Point mutation in the M.tuberculosis embR results in increased resistance to ethambutol.'	Mycobacterium tuberculosis embR mutant conferring resistance to ethambutol
embR.3003455.AL123456.3.1416180_1417347.4712	embR.3003455.AL123456.3.1416180_1417347.4712	1	1	27	618	embR	1167	1167	100.0	embR.l6.c4.ctg.1	2149	0.0	1	SNP	p	Q379R	0	.	.	1135	1137	CAG	1687	1689	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embR.3003455.AL123456.3.1416180_1417347.4712:1:1:Q379R:.:b'Point mutation in the M.tuberculosis embR results in increased resistance to ethambutol.'	Mycobacterium tuberculosis embR mutant conferring resistance to ethambutol
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	824	ethA_2	1470	1470	100.0	ethA_2.l6.c4.ctg.1	2208	0.0	1	SNP	p	P28S	0	.	.	82	84	CCG	424	426	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:P28S:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	824	ethA_2	1470	1470	100.0	ethA_2.l6.c4.ctg.1	2208	0.0	1	SNP	p	L35R	0	.	.	103	105	CTG	445	447	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:L35R:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	824	ethA_2	1470	1470	100.0	ethA_2.l6.c4.ctg.1	2208	0.0	1	SNP	p	G42D	0	.	.	124	126	GGC	466	468	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:G42D:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	824	ethA_2	1470	1470	100.0	ethA_2.l6.c4.ctg.1	2208	0.0	1	SNP	p	D56Y	0	.	.	166	168	GAC	508	510	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:D56Y:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	824	ethA_2	1470	1470	100.0	ethA_2.l6.c4.ctg.1	2208	0.0	1	SNP	p	D58G	0	.	.	172	174	GAC	514	516	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:D58G:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	824	ethA_2	1470	1470	100.0	ethA_2.l6.c4.ctg.1	2208	0.0	1	SNP	p	W69C	0	.	.	205	207	TGG	547	549	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:W69C:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	824	ethA_2	1470	1470	100.0	ethA_2.l6.c4.ctg.1	2208	0.0	1	SNP	p	H102P	0	.	.	304	306	CAC	646	648	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:H102P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	824	ethA_2	1470	1470	100.0	ethA_2.l6.c4.ctg.1	2208	0.0	1	SNP	p	Y141N	0	.	.	421	423	TAC	763	765	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:Y141N:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	824	ethA_2	1470	1470	100.0	ethA_2.l6.c4.ctg.1	2208	0.0	1	SNP	p	V179F	0	.	.	535	537	GTC	877	879	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:V179F:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	824	ethA_2	1470	1470	100.0	ethA_2.l6.c4.ctg.1	2208	0.0	1	SNP	p	T186P	0	.	.	556	558	ACG	898	900	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:T186P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	824	ethA_2	1470	1470	100.0	ethA_2.l6.c4.ctg.1	2208	0.0	1	SNP	p	T189R	0	.	.	565	567	ACG	907	909	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:T189R:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	824	ethA_2	1470	1470	100.0	ethA_2.l6.c4.ctg.1	2208	0.0	1	SNP	p	Q246P	0	.	.	736	738	CAG	1078	1080	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:Q246P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	824	ethA_2	1470	1470	100.0	ethA_2.l6.c4.ctg.1	2208	0.0	1	SNP	p	Q254P	0	.	.	760	762	CAG	1102	1104	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:Q254P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	824	ethA_2	1470	1470	100.0	ethA_2.l6.c4.ctg.1	2208	0.0	1	SNP	p	L267V	0	.	.	799	801	CTG	1141	1143	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:L267V:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	824	ethA_2	1470	1470	100.0	ethA_2.l6.c4.ctg.1	2208	0.0	1	SNP	p	S329P	0	.	.	985	987	TCA	1327	1329	TCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:S329P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	824	ethA_2	1470	1470	100.0	ethA_2.l6.c4.ctg.1	2208	0.0	1	SNP	p	A341V	0	.	.	1021	1023	GCA	1363	1365	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:A341V:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	824	ethA_2	1470	1470	100.0	ethA_2.l6.c4.ctg.1	2208	0.0	1	SNP	p	N345K	0	.	.	1033	1035	AAC	1375	1377	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:N345K:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	824	ethA_2	1470	1470	100.0	ethA_2.l6.c4.ctg.1	2208	0.0	1	SNP	p	A352E	0	.	.	1054	1056	GCG	1396	1398	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:A352E:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	824	ethA_2	1470	1470	100.0	ethA_2.l6.c4.ctg.1	2208	0.0	1	SNP	p	M372R	0	.	.	1114	1116	ATG	1456	1458	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:M372R:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	824	ethA_2	1470	1470	100.0	ethA_2.l6.c4.ctg.1	2208	0.0	1	SNP	p	A395D	0	.	.	1183	1185	GCC	1525	1527	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:A395D:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	824	ethA_2	1470	1470	100.0	ethA_2.l6.c4.ctg.1	2208	0.0	1	SNP	p	C403Y	0	.	.	1207	1209	TGT	1549	1551	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:C403Y:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	824	ethA_2	1470	1470	100.0	ethA_2.l6.c4.ctg.1	2208	0.0	1	SNP	p	F480S	0	.	.	1438	1440	TTC	1780	1782	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:F480S:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	530	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2352	0.0	1	SNP	p	T20P	0	.	.	58	60	ACT	514	516	ACT	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:T20P:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	530	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2352	0.0	1	SNP	p	E40Q	0	.	.	118	120	GAG	574	576	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E40Q:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	530	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2352	0.0	1	SNP	p	E40G	0	.	.	118	120	GAG	574	576	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E40G:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	530	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2352	0.0	1	SNP	p	I43S	0	.	.	127	129	ATC	583	585	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:I43S:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	530	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2352	0.0	1	SNP	p	I43A	0	.	.	127	129	ATC	583	585	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:I43A:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	530	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2352	0.0	1	SNP	p	I43T	0	.	.	127	129	ATC	583	585	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:I43T:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	530	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2352	0.0	1	SNP	p	R49P	0	.	.	145	147	CGG	601	603	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:R49P:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	530	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2352	0.0	1	SNP	p	R49W	0	.	.	145	147	CGG	601	603	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:R49W:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	530	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2352	0.0	1	SNP	p	L56V	0	.	.	166	168	CTG	622	624	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:L56V:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	530	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2352	0.0	1	SNP	p	R91W	0	.	.	271	273	CGG	727	729	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:R91W:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	530	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2352	0.0	1	SNP	p	S150C	0	.	.	448	450	AGC	904	906	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:S150C:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	530	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2352	0.0	1	SNP	p	S150G	0	.	.	448	450	AGC	904	906	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:S150G:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	530	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2352	0.0	1	SNP	p	E153G	0	.	.	457	459	GAG	913	915	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E153G:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	530	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2352	0.0	1	SNP	p	E153A	0	.	.	457	459	GAG	913	915	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E153A:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	530	folC	1464	1464	100.0	folC.l15.c4.ctg.1	2352	0.0	1	SNP	p	A420V	0	.	.	1258	1260	GCG	1714	1716	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:A420V:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	424	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1575	0.0	1	SNP	p	G30R	0	.	.	88	90	GGT	506	508	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G30R:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	424	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1575	0.0	1	SNP	p	G37V	0	.	.	109	111	GGA	527	529	GGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G37V:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	424	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1575	0.0	1	SNP	p	W45C	0	.	.	133	135	TGG	551	553	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:W45C:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	424	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1575	0.0	1	SNP	p	W45S	0	.	.	133	135	TGG	551	553	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:W45S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	424	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1575	0.0	1	SNP	p	R47Q	0	.	.	139	141	CGG	557	559	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:R47Q:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	424	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1575	0.0	1	SNP	p	H48Y	0	.	.	142	144	CAT	560	562	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:H48Y:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	424	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1575	0.0	1	SNP	p	L49F	0	.	.	145	147	CTA	563	565	CTA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:L49F:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	424	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1575	0.0	1	SNP	p	I55S	0	.	.	163	165	ATC	581	583	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:I55S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	424	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1575	0.0	1	SNP	p	D67H	0	.	.	199	201	GAT	617	619	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:D67H:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	424	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1575	0.0	1	SNP	p	S70R	0	.	.	208	210	AGC	626	628	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:S70R:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	424	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1575	0.0	1	SNP	p	G71V	0	.	.	211	213	GGA	629	631	GGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G71V:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	424	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1575	0.0	1	SNP	p	P75S	0	.	.	223	225	CCG	641	643	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:P75S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	424	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1575	0.0	1	SNP	p	L79S	0	.	.	235	237	TTG	653	655	TTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:L79S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	424	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1575	0.0	1	SNP	p	L79F	0	.	.	235	237	TTG	653	655	TTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:L79F:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	424	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1575	0.0	1	SNP	p	P84C	0	.	.	250	252	CCG	668	670	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:P84C:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	424	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1575	0.0	1	SNP	p	P84L	0	.	.	250	252	CCG	668	670	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:P84L:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	424	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1575	0.0	1	SNP	p	E92A	0	.	.	274	276	GAA	692	694	GAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:E92A:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	424	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1575	0.0	1	SNP	p	G117E	0	.	.	349	351	GGG	767	769	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G117E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	424	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1575	0.0	1	SNP	p	V124G	0	.	.	370	372	GTG	788	790	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:V124G:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	424	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1575	0.0	1	SNP	p	Q127P	0	.	.	379	381	CAA	797	799	CAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:Q127P:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	424	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1575	0.0	1	SNP	p	A134E	0	.	.	400	402	GCG	818	820	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A134E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	424	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1575	0.0	1	SNP	p	A138E	0	.	.	412	414	GCG	830	832	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A138E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	424	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1575	0.0	1	SNP	p	V139A	0	.	.	415	417	GTG	833	835	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:V139A:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	424	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1575	0.0	1	SNP	p	W148R	0	.	.	442	444	TGG	860	862	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:W148R:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	424	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1575	0.0	1	SNP	p	G164C	0	.	.	490	492	GGC	908	910	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G164C:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	424	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1575	0.0	1	SNP	p	A183E	0	.	.	547	549	GCG	965	967	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A183E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	424	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1575	0.0	1	SNP	p	A183T	0	.	.	547	549	GCG	965	967	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A183T:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	424	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1575	0.0	1	SNP	p	V188M	0	.	.	562	564	GTG	980	982	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:V188M:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	424	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1575	0.0	1	SNP	p	V188G	0	.	.	562	564	GTG	980	982	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:V188G:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	424	gidB	675	675	99.85	gidB.l6.c4.ctg.1	1575	0.0	1	SNP	p	A200E	0	.	.	598	600	GCG	1016	1018	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A200E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1270	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3021	0.0	0	.	p	.	0	E21Q	NONSYN	61	63	GAG	309	311	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1270	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3021	0.0	0	.	p	.	0	S95T	NONSYN	283	285	AGC	531	533	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1270	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3021	0.0	0	.	p	.	0	G668D	NONSYN	2002	2004	GGC	2250	2252	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1270	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3021	0.0	1	SNP	p	A74S	0	.	.	220	222	GCC	468	470	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:A74S:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1270	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3021	0.0	1	SNP	p	T80A	0	.	.	238	240	ACC	486	488	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:T80A:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1270	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3021	0.0	1	SNP	p	G88A	0	.	.	262	264	GGC	510	512	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:G88A:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1270	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3021	0.0	1	SNP	p	G88C	0	.	.	262	264	GGC	510	512	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:G88C:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1270	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3021	0.0	1	SNP	p	D89G	0	.	.	265	267	GAC	513	515	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D89G:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1270	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3021	0.0	1	SNP	p	D89V	0	.	.	265	267	GAC	513	515	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D89V:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1270	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3021	0.0	1	SNP	p	D89N	0	.	.	265	267	GAC	513	515	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D89N:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1270	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3021	0.0	1	SNP	p	A90V	0	.	.	268	270	GCG	516	518	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:A90V:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1270	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3021	0.0	1	SNP	p	A90G	0	.	.	268	270	GCG	516	518	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:A90G:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1270	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3021	0.0	1	SNP	p	S91P	0	.	.	271	273	TCG	519	521	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:S91P:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1270	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3021	0.0	1	SNP	p	D94G	0	.	.	280	282	GAC	528	530	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94G:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1270	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3021	0.0	1	SNP	p	D94A	0	.	.	280	282	GAC	528	530	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94A:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1270	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3021	0.0	1	SNP	p	D94T	0	.	.	280	282	GAC	528	530	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94T:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1270	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3021	0.0	1	SNP	p	D94V	0	.	.	280	282	GAC	528	530	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94V:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1270	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3021	0.0	1	SNP	p	D94N	0	.	.	280	282	GAC	528	530	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94N:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1270	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3021	0.0	1	SNP	p	D94Y	0	.	.	280	282	GAC	528	530	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94Y:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1270	gyrA_1	2517	2517	99.88	gyrA_1.l6.c4.ctg.1	3021	0.0	1	SNP	p	P102H	0	.	.	304	306	CCC	552	554	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:P102H:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1182	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	3243	0.0	1	SNP	p	V340L	0	.	.	1018	1020	GTG	1525	1527	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:V340L:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1182	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	3243	0.0	1	SNP	p	D500H	0	.	.	1498	1500	GAC	2005	2007	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:D500H:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1182	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	3243	0.0	1	SNP	p	N538D	0	.	.	1612	1614	AAC	2119	2121	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:N538D:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1182	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	3243	0.0	1	SNP	p	N538K	0	.	.	1612	1614	AAC	2119	2121	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:N538K:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1182	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	3243	0.0	1	SNP	p	T539P	0	.	.	1615	1617	ACC	2122	2124	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:T539P:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1182	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	3243	0.0	1	SNP	p	T539N	0	.	.	1615	1617	ACC	2122	2124	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:T539N:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1182	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	3243	0.0	1	SNP	p	E540D	0	.	.	1618	1620	GAA	2125	2127	GAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:E540D:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1182	gyrB_6	2145	2145	99.95	gyrB_6.l15.c4.ctg.1	3243	0.0	1	SNP	p	E540V	0	.	.	1618	1620	GAA	2125	2127	GAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:E540V:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	336	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1662	0.0	1	SNP	p	I16T	0	.	.	46	48	ATC	505	507	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I16T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	336	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1662	0.0	1	SNP	p	I21T	0	.	.	61	63	ATC	520	522	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I21T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	336	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1662	0.0	1	SNP	p	I21V	0	.	.	61	63	ATC	520	522	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I21V:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	336	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1662	0.0	1	SNP	p	I47T	0	.	.	139	141	ATT	598	600	ATT	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I47T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	336	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1662	0.0	1	SNP	p	V78A	0	.	.	232	234	GTG	691	693	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:V78A:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	336	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1662	0.0	1	SNP	p	S94A	0	.	.	280	282	TCG	739	741	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:S94A:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	336	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1662	0.0	1	SNP	p	I95P	0	.	.	283	285	ATT	742	744	ATT	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I95P:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	336	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1662	0.0	1	SNP	p	G141E	0	.	.	421	423	GGA	880	882	GGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:G141E:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	336	inhA	810	810	100.0	inhA.l15.c4.ctg.1	1662	0.0	1	SNP	p	I194T	0	.	.	580	582	ATC	1039	1041	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I194T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	27	964	iniA	1923	1923	100.0	iniA.l15.c4.ctg.1	2453	0.0	1	SNP	p	P3A	0	.	.	7	9	CCC	233	235	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:P3A:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	27	964	iniA	1923	1923	100.0	iniA.l15.c4.ctg.1	2453	0.0	1	SNP	p	G308R	0	.	.	922	924	GGG	1148	1150	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:G308R:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	27	964	iniA	1923	1923	100.0	iniA.l15.c4.ctg.1	2453	0.0	1	SNP	p	S501W	0	.	.	1501	1503	TCG	1727	1729	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:S501W:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	27	964	iniA	1923	1923	100.0	iniA.l15.c4.ctg.1	2453	0.0	1	SNP	p	R537H	0	.	.	1609	1611	CGC	1835	1837	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:R537H:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniB.3004135.AL123456.3.409361_410801.5509	iniB.3004135.AL123456.3.409361_410801.5509	1	1	539	406	iniB	1440	1440	99.93	iniB.l6.c4.ctg.1	2103	0.0	0	.	p	.	0	Q416P	NONSYN	1246	1248	CAG	1542	1544	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis iniB with mutation conferring resistance to ethambutol
iniB.3004135.AL123456.3.409361_410801.5509	iniB.3004135.AL123456.3.409361_410801.5509	1	1	539	406	iniB	1440	1440	99.93	iniB.l6.c4.ctg.1	2103	0.0	1	SNP	p	A47T	0	.	.	139	141	GCC	435	437	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniB.3004135.AL123456.3.409361_410801.5509:1:1:A47T:.:b'Point mutations in M. tuberculosis iniB shown to confer resistance to ethambutol.'	Mycobacterium tuberculosis iniB with mutation conferring resistance to ethambutol
iniC.3003451.AL123456.1.412756_414238.2100	iniC.3003451.AL123456.1.412756_414238.2100	1	1	27	692	iniC	1482	1482	100.0	iniC.l6.c4.ctg.1	2505	0.0	1	SNP	p	W83G	0	.	.	247	249	TGG	797	799	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniC.3003451.AL123456.1.412756_414238.2100:1:1:W83G:.:b'Specific mutations that occurs on Mycobacterium tuberculosis iniC causing it to be ethambutol resistant.'	Mycobacterium tuberculosis iniC mutant conferring resistance to ethambutol
iniC.3003451.AL123456.1.412756_414238.2100	iniC.3003451.AL123456.1.412756_414238.2100	1	1	27	692	iniC	1482	1482	100.0	iniC.l6.c4.ctg.1	2505	0.0	1	SNP	p	P248A	0	.	.	742	744	CCG	1292	1294	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniC.3003451.AL123456.1.412756_414238.2100:1:1:P248A:.:b'Specific mutations that occurs on Mycobacterium tuberculosis iniC causing it to be ethambutol resistant.'	Mycobacterium tuberculosis iniC mutant conferring resistance to ethambutol
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	582	kasA	1251	1251	100.0	kasA.l15.c4.ctg.1	2123	0.0	1	SNP	p	D66N	0	.	.	196	198	GAT	655	657	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:D66N:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	582	kasA	1251	1251	100.0	kasA.l15.c4.ctg.1	2123	0.0	1	SNP	p	R121K	0	.	.	361	363	AGG	820	822	AGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:R121K:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	582	kasA	1251	1251	100.0	kasA.l15.c4.ctg.1	2123	0.0	1	SNP	p	G269S	0	.	.	805	807	GGT	1264	1266	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:G269S:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	582	kasA	1251	1251	100.0	kasA.l15.c4.ctg.1	2123	0.0	1	SNP	p	G312S	0	.	.	934	936	GGC	1393	1395	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:G312S:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	582	kasA	1251	1251	100.0	kasA.l15.c4.ctg.1	2123	0.0	1	SNP	p	G387D	0	.	.	1159	1161	GGC	1618	1620	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:G387D:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	582	kasA	1251	1251	100.0	kasA.l15.c4.ctg.1	2123	0.0	1	SNP	p	F413L	0	.	.	1237	1239	TTC	1696	1698	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:F413L:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1116	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	3175	0.0	0	.	p	.	0	R463L	NONSYN	1387	1389	CGG	1894	1896	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1116	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	3175	0.0	1	SNP	p	G33V	0	.	.	97	99	GGC	604	606	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G33V:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1116	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	3175	0.0	1	SNP	p	W91R	0	.	.	271	273	TGG	778	780	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:W91R:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1116	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	3175	0.0	1	SNP	p	A110V	0	.	.	328	330	GCC	835	837	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:A110V:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1116	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	3175	0.0	1	SNP	p	G111S	0	.	.	331	333	GGC	838	840	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G111S:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1116	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	3175	0.0	1	SNP	p	G125S	0	.	.	373	375	GGC	880	882	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G125S:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1116	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	3175	0.0	1	SNP	p	M126I	0	.	.	376	378	ATG	883	885	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:M126I:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1116	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	3175	0.0	1	SNP	p	Q127P	0	.	.	379	381	CAG	886	888	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:Q127P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1116	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	3175	0.0	1	SNP	p	D142G	0	.	.	424	426	GAC	931	933	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:D142G:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1116	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	3175	0.0	1	SNP	p	L147P	0	.	.	439	441	CTG	946	948	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:L147P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1116	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	3175	0.0	1	SNP	p	A264V	0	.	.	790	792	GCG	1297	1299	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:A264V:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1116	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	3175	0.0	1	SNP	p	A312P	0	.	.	934	936	GCG	1441	1443	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:A312P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1116	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	3175	0.0	1	SNP	p	S315N	0	.	.	943	945	AGC	1450	1452	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:S315N:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1116	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	3175	0.0	1	SNP	p	S315G	0	.	.	943	945	AGC	1450	1452	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:S315G:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1116	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	3175	0.0	1	SNP	p	S315T	0	.	.	943	945	AGC	1450	1452	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:S315T:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1116	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	3175	0.0	1	SNP	p	H417Q	0	.	.	1249	1251	CAC	1756	1758	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:H417Q:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1116	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	3175	0.0	1	SNP	p	Q461P	0	.	.	1381	1383	CAG	1888	1890	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:Q461P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1116	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	3175	0.0	1	SNP	p	G490S	0	.	.	1468	1470	GGC	1975	1977	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G490S:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1116	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	3175	0.0	1	SNP	p	N508D	0	.	.	1522	1524	AAC	2029	2031	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:N508D:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1116	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	3175	0.0	1	SNP	p	E607A	0	.	.	1819	1821	GAG	2326	2328	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:E607A:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	1116	katG_1	2223	2223	99.96	katG_1.l6.c4.ctg.1	3175	0.0	1	SNP	p	N660D	0	.	.	1978	1980	AAC	2485	2487	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:N660D:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
mfpA.3003035.AL123456.1.3773015_3773567.4588	mfpA.3003035.AL123456.1.3773015_3773567.4588	1	0	27	286	mfpA	552	552	100.0	mfpA.l15.c4.ctg.1	1079	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mfpA;b'mfpA is a qnr homolog and a pentapeptide repeat protein that confers resistance to fluoroquinolones in Mycolicibacterium smegmatis.'
mshA.3005108.NC_000962.3.575347_576790.6150	mshA.3005108.NC_000962.3.575347_576790.6150	1	1	27	540	mshA_1	1443	1443	100.0	mshA_1.l6.c4.ctg.1	1926	0.0	1	SNP	p	F355S	0	.	.	1063	1065	TTC	1281	1283	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	mshA.3005108.NC_000962.3.575347_576790.6150:1:1:F355S:.:b'Mutations in Mycobacterium tuberculosis mshA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis mshA mutations conferring resistance to prothionamide
murA.3003784.HE608151.1.1472985_1474242.3555	murA.3003784.HE608151.1.1472985_1474242.3555	1	1	27	618	murA_4	1257	1257	100.0	murA_4.l6.c30.ctg.1	2021	0.0	1	SNP	p	C117D	1	.	.	349	351	GAC	748	750	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	murA.3003784.HE608151.1.1472985_1474242.3555:1:1:C117D:.:b'Mycobacterium tuberculosis murA confers intrinsic resistance to fosfomycin. The presence of an aspartic acid residue in place of the critical cysteine at position 117 that enables fosfomycin binding is believed to be responsible for this intrinsic resistance.'	Mycobacterium tuberculosis intrinsic murA conferring resistance to fosfomycin
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	M1S	0	.	.	1	3	ATG	241	243	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:M1S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	A3E	0	.	.	7	9	GCG	247	249	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A3E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	L4W	0	.	.	10	12	TTG	250	252	TTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L4W:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	I5S	0	.	.	13	15	ATC	253	255	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:I5S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	V7D	0	.	.	19	21	GTC	259	261	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V7D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	V7G	0	.	.	19	21	GTC	259	261	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V7G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	V7F	0	.	.	19	21	GTC	259	261	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V7F:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	D8Y	0	.	.	22	24	GAC	262	264	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D8Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	V9G	0	.	.	25	27	GTG	265	267	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V9G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	V9A	0	.	.	25	27	GTG	265	267	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V9A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	Q10R	0	.	.	28	30	CAG	268	270	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q10R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	Q10P	0	.	.	28	30	CAG	268	270	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q10P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	Q10K	0	.	.	28	30	CAG	268	270	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q10K:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	D12E	0	.	.	34	36	GAC	274	276	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D12E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	D12A	0	.	.	34	36	GAC	274	276	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D12A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	D12N	0	.	.	34	36	GAC	274	276	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D12N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	C14R	0	.	.	40	42	TGC	280	282	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C14R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	C14Y	0	.	.	40	42	TGC	280	282	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C14Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	G17S	0	.	.	49	51	GGC	289	291	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G17S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	G17D	0	.	.	49	51	GGC	289	291	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G17D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	L19P	0	.	.	55	57	CTG	295	297	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L19P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	G23V	0	.	.	67	69	GGT	307	309	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G23V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	A26G	0	.	.	76	78	GCG	316	318	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A26G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	L27P	0	.	.	79	81	CTG	319	321	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L27P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	Y34S	0	.	.	100	102	TAC	340	342	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y34S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	Y41H	0	.	.	121	123	TAC	361	363	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y41H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	V45G	0	.	.	133	135	GTG	373	375	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V45G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	A46E	0	.	.	136	138	GCA	376	378	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A46E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	A46V	0	.	.	136	138	GCA	376	378	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A46V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	T47S	0	.	.	139	141	ACC	379	381	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T47S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	T47P	0	.	.	139	141	ACC	379	381	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T47P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	T47A	0	.	.	139	141	ACC	379	381	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T47A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	D49V	0	.	.	145	147	GAC	385	387	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D49V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	D49A	0	.	.	145	147	GAC	385	387	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D49A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	H51Y	0	.	.	151	153	CAC	391	393	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H51Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	H51Q	0	.	.	151	153	CAC	391	393	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H51Q:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	D53A	0	.	.	157	159	GAC	397	399	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D53A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	P54L	0	.	.	160	162	CCG	400	402	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P54L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	P54T	0	.	.	160	162	CCG	400	402	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P54T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	H57D	0	.	.	169	171	CAC	409	411	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H57D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	H57Q	0	.	.	169	171	CAC	409	411	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H57Q:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	F58L	0	.	.	172	174	TTC	412	414	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:F58L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	P62H	0	.	.	184	186	CCG	424	426	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P62H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	S66P	0	.	.	196	198	TCG	436	438	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S66P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	S67P	0	.	.	199	201	TCG	439	441	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S67P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	W68R	0	.	.	202	204	TGG	442	444	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	W68L	0	.	.	202	204	TGG	442	444	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	W68S	0	.	.	202	204	TGG	442	444	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	W68G	0	.	.	202	204	TGG	442	444	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	W68C	0	.	.	202	204	TGG	442	444	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68C:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	P69R	0	.	.	205	207	CCA	445	447	CCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P69R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	H71E	0	.	.	211	213	CAT	451	453	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H71E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	C72W	0	.	.	214	216	TGC	454	456	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C72W:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	C72R	0	.	.	214	216	TGC	454	456	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C72R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	T76I	0	.	.	226	228	ACT	466	468	ACT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T76I:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	T76P	0	.	.	226	228	ACT	466	468	ACT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T76P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	G78D	0	.	.	232	234	GGC	472	474	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G78D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	H82R	0	.	.	244	246	CAT	484	486	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H82R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	L85P	0	.	.	253	255	CTG	493	495	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L85P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	L85R	0	.	.	253	255	CTG	493	495	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L85R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	I90S	0	.	.	268	270	ATC	508	510	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:I90S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	F94P	0	.	.	280	282	TTC	520	522	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:F94P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	K96Q	0	.	.	286	288	AAG	526	528	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96Q:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	K96M	0	.	.	286	288	AAG	526	528	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96M:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	K96N	0	.	.	286	288	AAG	526	528	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	K96E	0	.	.	286	288	AAG	526	528	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	G97S	0	.	.	289	291	GGT	529	531	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G97S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	T100P	0	.	.	298	300	ACC	538	540	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T100P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	A102T	0	.	.	304	306	GCG	544	546	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A102T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	A102V	0	.	.	304	306	GCG	544	546	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A102V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	Y103S	0	.	.	307	309	TAC	547	549	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y103S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	Y103H	0	.	.	307	309	TAC	547	549	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y103H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	S104C	0	.	.	310	312	AGC	550	552	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S104C:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	L116R	0	.	.	346	348	CTG	586	588	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L116R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	N118T	0	.	.	352	354	AAT	592	594	AAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:N118T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	W119R	0	.	.	355	357	TGG	595	597	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W119R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	R121P	0	.	.	361	363	CGG	601	603	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:R121P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	V125D	0	.	.	373	375	GTC	613	615	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V125D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	G132S	0	.	.	394	396	GGT	634	636	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G132S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	I133T	0	.	.	397	399	ATT	637	639	ATT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:I133T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	A134V	0	.	.	400	402	GCC	640	642	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A134V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	T135P	0	.	.	403	405	ACC	643	645	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T135P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	D136Y	0	.	.	406	408	GAT	646	648	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D136Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	D136H	0	.	.	406	408	GAT	646	648	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D136H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	D136N	0	.	.	406	408	GAT	646	648	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D136N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	H137P	0	.	.	409	411	CAT	649	651	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H137P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	H137R	0	.	.	409	411	CAT	649	651	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H137R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	C138S	0	.	.	412	414	TGT	652	654	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C138S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	C138W	0	.	.	412	414	TGT	652	654	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C138W:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	C138Y	0	.	.	412	414	TGT	652	654	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C138Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	V139M	0	.	.	415	417	GTG	655	657	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V139M:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	V139A	0	.	.	415	417	GTG	655	657	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V139A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	V139L	0	.	.	415	417	GTG	655	657	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V139L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	R140G	0	.	.	418	420	CGC	658	660	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:R140G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	Q141P	0	.	.	421	423	CAG	661	663	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q141P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	T142K	0	.	.	424	426	ACG	664	666	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T142K:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	T142M	0	.	.	424	426	ACG	664	666	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T142M:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	A146T	0	.	.	436	438	GCG	676	678	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A146T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	R154G	0	.	.	460	462	AGG	700	702	AGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:R154G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	V155G	0	.	.	463	465	GTG	703	705	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V155G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	V157G	0	.	.	469	471	GTG	709	711	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V157G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	L159R	0	.	.	475	477	CTG	715	717	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L159R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	T160P	0	.	.	478	480	ACA	718	720	ACA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T160P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	A161G	0	.	.	481	483	GCG	721	723	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A161G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	A161P	0	.	.	481	483	GCG	721	723	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A161P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	S164P	0	.	.	490	492	TCG	730	732	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S164P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	T168N	0	.	.	502	504	ACC	742	744	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T168N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	A171V	0	.	.	511	513	GCG	751	753	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A171V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	A171P	0	.	.	511	513	GCG	751	753	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A171P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	A171T	0	.	.	511	513	GCG	751	753	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A171T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	L172A	0	.	.	514	516	CTG	754	756	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L172A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	L172P	0	.	.	514	516	CTG	754	756	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L172P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	E174G	0	.	.	520	522	GAG	760	762	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:E174G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	M175V	0	.	.	523	525	ATG	763	765	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:M175V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	V180F	0	.	.	538	540	GTC	778	780	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V180F:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	360	pncA	561	561	99.82	pncA.l15.c4.ctg.1	1258	0.0	1	SNP	p	L182S	0	.	.	544	546	TTG	784	786	TTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L182S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
ribD.3004184.AL123456.3.2986838_2987615.5511	ribD.3004184.AL123456.3.2986838_2987615.5511	1	1	27	440	ribD	777	777	100.0	ribD.l15.c4.ctg.1	1875	0.0	1	SNP	p	G8R	0	.	.	22	24	GGA	582	584	GGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	ribD.3004184.AL123456.3.2986838_2987615.5511:1:1:G8R:.:b'ribD is a Mycobacterium tuberculosis riboflavin biosynthesis enzyme. Point mutations in ribD cause enzyme overexpression, which allows the C-terminal reductase domain to act as an alternative dihydrofolate reductase. Thus, mutations in ribD confer resistance to DHFR inhibitors such as para-aminosalicylic acid.'	Mycobacterium tuberculosis ribD with mutation conferring resistance to para-aminosalicylic acid
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	1606	rpoB_1	3519	3519	99.94	rpoB_1.l15.c17.ctg.1	4165	0.0	1	SNP	p	V146F	0	.	.	436	438	GTG	712	714	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:V146F:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	1606	rpoB_1	3519	3519	99.94	rpoB_1.l15.c17.ctg.1	4165	0.0	1	SNP	p	S450L	0	.	.	1348	1350	TCG	1624	1626	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:S450L:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	1606	rpoB_1	3519	3519	99.94	rpoB_1.l15.c17.ctg.1	4165	0.0	1	SNP	p	F505L	0	.	.	1513	1515	TTC	1789	1791	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:F505L:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	1606	rpoB_1	3519	3519	99.94	rpoB_1.l15.c17.ctg.1	4165	0.0	1	SNP	p	T508N	0	.	.	1522	1524	ACG	1798	1800	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508N:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	1606	rpoB_1	3519	3519	99.94	rpoB_1.l15.c17.ctg.1	4165	0.0	1	SNP	p	T508S	0	.	.	1522	1524	ACG	1798	1800	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508S:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	1606	rpoB_1	3519	3519	99.94	rpoB_1.l15.c17.ctg.1	4165	0.0	1	SNP	p	T508H	0	.	.	1522	1524	ACG	1798	1800	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508H:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	1606	rpoB_1	3519	3519	99.94	rpoB_1.l15.c17.ctg.1	4165	0.0	1	SNP	p	T508A	0	.	.	1522	1524	ACG	1798	1800	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508A:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	1606	rpoB_1	3519	3519	99.94	rpoB_1.l15.c17.ctg.1	4165	0.0	1	SNP	p	T508P	0	.	.	1522	1524	ACG	1798	1800	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508P:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	1606	rpoB_1	3519	3519	99.94	rpoB_1.l15.c17.ctg.1	4165	0.0	1	SNP	p	L511R	1	.	.	1531	1533	CGC	1807	1809	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:L511R:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	1606	rpoB_1	3519	3519	99.94	rpoB_1.l15.c17.ctg.1	4165	0.0	1	SNP	p	D516G	1	.	.	1546	1548	GGC	1822	1824	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:D516G:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	1606	rpoB_1	3519	3519	99.94	rpoB_1.l15.c17.ctg.1	4165	0.0	1	SNP	p	H526T	1	.	.	1576	1578	ACC	1852	1854	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:H526T:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003284.AL450380.1.2273268_2276805.4581	rpoB.3003284.AL450380.1.2273268_2276805.4581	1	1	16	58	rpoB_2	3537	368	93.21	rpoB_2.l15.c4.ctg.2	447	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Mycobacterium leprae rpoB mutations conferring resistance to rifampicin
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	672	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	2431	0.0	1	SNP	p	D123A	0	.	.	367	369	GAC	873	875	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:D123A:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	672	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	2431	0.0	1	SNP	p	S324F	0	.	.	970	972	TCC	1476	1478	TCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:S324F:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	672	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	2431	0.0	1	SNP	p	E325K	0	.	.	973	975	GAG	1479	1481	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:E325K:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	672	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	2431	0.0	1	SNP	p	G341R	0	.	.	1021	1023	GGC	1527	1529	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:G341R:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	672	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	2431	0.0	1	SNP	p	D342N	0	.	.	1024	1026	GAC	1530	1532	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:D342N:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	672	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	2431	0.0	1	SNP	p	D343N	0	.	.	1027	1029	GAC	1533	1535	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:D343N:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	672	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	2431	0.0	1	SNP	p	A344P	0	.	.	1030	1032	GCG	1536	1538	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:A344P:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	672	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	2431	0.0	1	SNP	p	I351F	0	.	.	1051	1053	ATC	1557	1559	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:I351F:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	27	310	rpsL	375	375	100.0	rpsL.l6.c4.ctg.1	1363	0.0	1	SNP	p	T40I	0	.	.	118	120	ACC	560	562	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:T40I:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	27	310	rpsL	375	375	100.0	rpsL.l6.c4.ctg.1	1363	0.0	1	SNP	p	K43R	0	.	.	127	129	AAG	569	571	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:K43R:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	27	310	rpsL	375	375	100.0	rpsL.l6.c4.ctg.1	1363	0.0	1	SNP	p	K88R	0	.	.	262	264	AAG	704	706	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:K88R:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	27	310	rpsL	375	375	100.0	rpsL.l6.c4.ctg.1	1363	0.0	1	SNP	p	K88Q	0	.	.	262	264	AAG	704	706	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:K88Q:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	386	thyA	792	792	100.0	thyA.l6.c4.ctg.1	1360	0.0	1	SNP	p	T22A	0	.	.	64	66	ACC	242	244	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:T22A:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	386	thyA	792	792	100.0	thyA.l6.c4.ctg.1	1360	0.0	1	SNP	p	Y36C	0	.	.	106	108	TAT	284	286	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:Y36C:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	386	thyA	792	792	100.0	thyA.l6.c4.ctg.1	1360	0.0	1	SNP	p	H75N	0	.	.	223	225	CAC	401	403	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:H75N:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	386	thyA	792	792	100.0	thyA.l6.c4.ctg.1	1360	0.0	1	SNP	p	V77F	0	.	.	229	231	GTC	407	409	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:V77F:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	386	thyA	792	792	100.0	thyA.l6.c4.ctg.1	1360	0.0	1	SNP	p	W83C	0	.	.	247	249	TGG	425	427	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:W83C:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	386	thyA	792	792	100.0	thyA.l6.c4.ctg.1	1360	0.0	1	SNP	p	G91R	0	.	.	271	273	GGG	449	451	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:G91R:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	386	thyA	792	792	100.0	thyA.l6.c4.ctg.1	1360	0.0	1	SNP	p	W101R	0	.	.	301	303	TGG	479	481	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:W101R:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	386	thyA	792	792	100.0	thyA.l6.c4.ctg.1	1360	0.0	1	SNP	p	S105P	0	.	.	313	315	TCC	491	493	TCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:S105P:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	386	thyA	792	792	100.0	thyA.l6.c4.ctg.1	1360	0.0	1	SNP	p	R126Q	0	.	.	376	378	CGG	554	556	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:R126Q:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	386	thyA	792	792	100.0	thyA.l6.c4.ctg.1	1360	0.0	1	SNP	p	F152V	0	.	.	454	456	TTC	632	634	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:F152V:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	386	thyA	792	792	100.0	thyA.l6.c4.ctg.1	1360	0.0	1	SNP	p	C161T	0	.	.	481	483	TGT	659	661	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:C161T:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	386	thyA	792	792	100.0	thyA.l6.c4.ctg.1	1360	0.0	1	SNP	p	T202A	0	.	.	604	606	ACC	782	784	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:T202A:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	386	thyA	792	792	100.0	thyA.l6.c4.ctg.1	1360	0.0	1	SNP	p	H207R	0	.	.	619	621	CAC	797	799	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:H207R:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	386	thyA	792	792	100.0	thyA.l6.c4.ctg.1	1360	0.0	1	SNP	p	P224L	0	.	.	670	672	CCG	848	850	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:P224L:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	386	thyA	792	792	100.0	thyA.l6.c4.ctg.1	1360	0.0	1	SNP	p	R235P	0	.	.	703	705	CGG	881	883	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:R235P:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	336	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1406	0.0	1	SNP	p	R14W	0	.	.	40	42	CGG	214	216	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:R14W:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	336	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1406	0.0	1	SNP	p	A67E	0	.	.	199	201	GCG	373	375	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:A67E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	336	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1406	0.0	1	SNP	p	K69E	0	.	.	205	207	AAA	379	381	AAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:K69E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	336	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1406	0.0	1	SNP	p	A91E	0	.	.	271	273	GCA	445	447	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:A91E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	336	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1406	0.0	1	SNP	p	L118P	0	.	.	352	354	CTG	526	528	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:L118P:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	336	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1406	0.0	1	SNP	p	V128E	0	.	.	382	384	GTG	556	558	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:V128E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	336	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1406	0.0	1	SNP	p	L150P	0	.	.	448	450	CTG	622	624	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:L150P:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	336	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1406	0.0	1	SNP	p	P183L	0	.	.	547	549	CCG	721	723	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:P183L:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	336	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1406	0.0	1	SNP	p	F185L	0	.	.	553	555	TTT	727	729	TTT	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:F185L:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	336	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1406	0.0	1	SNP	p	N236K	0	.	.	706	708	AAT	880	882	AAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:N236K:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	336	tlyA	807	807	100.0	tlyA.l15.c4.ctg.1	1406	0.0	1	SNP	p	E238K	0	.	.	712	714	GAG	886	888	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:E238K:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
